BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25345495)

  • 1. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
    Kooijman S; Meurs I; van der Stoep M; Habets KL; Lammers B; Berbée JF; Havekes LM; van Eck M; Romijn JA; Korporaal SJ; Rensen PC
    J Thromb Haemost; 2015 Jan; 13(1):126-35. PubMed ID: 25345495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report.
    Johansson ME; Ulleryd MA; Bernardi A; Lundberg AM; Andersson A; Folkersen L; Fogelstrand L; Islander U; Yan ZQ; Hansson GK
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2632-6. PubMed ID: 25324572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.
    Karshovska E; Zhao Z; Blanchet X; Schmitt MM; Bidzhekov K; Soehnlein O; von Hundelshausen P; Mattheij NJ; Cosemans JM; Megens RT; Koeppel TA; Schober A; Hackeng TM; Weber C; Koenen RR
    Circ Res; 2015 Feb; 116(4):587-99. PubMed ID: 25472975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.
    Koltsova EK; Sundd P; Zarpellon A; Ouyang H; Mikulski Z; Zampolli A; Ruggeri ZM; Ley K
    Thromb Haemost; 2014 Dec; 112(6):1252-63. PubMed ID: 25104056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions.
    Thiem K; Hoeke G; Zhou E; Hijmans A; Houben T; Boels MG; Mol IM; Lutgens E; Shiri-Sverdlov R; Bussink J; Kanneganti TD; Boon MR; Stienstra R; Tack CJ; Rensen PC; Netea MG; Berbée JF; van Diepen JA
    Diab Vasc Dis Res; 2020; 17(1):1479164119892140. PubMed ID: 31868000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice by Activating α7 Nicotinic Acetylcholine Receptor on Mast Cells.
    Wang C; Chen H; Zhu W; Xu Y; Liu M; Zhu L; Yang F; Zhang L; Liu X; Zhong Z; Zhao J; Jiang J; Xiang M; Yu H; Hu X; Lu H; Wang J
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):53-65. PubMed ID: 27834689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.
    Krishack PA; Bhanvadia CV; Lukens J; Sontag TJ; De Beer MC; Getz GS; Reardon CA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor.
    Lee RH; Vazquez G
    PLoS One; 2015; 10(3):e0124584. PubMed ID: 25826262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic Stabilin-1 deficiency does not influence atherosclerosis susceptibility in LDL receptor knockout mice.
    Nahon JE; Hoekstra M; van Hulst S; Manta C; Goerdt S; Geerling JJ; Géraud C; Van Eck M
    Atherosclerosis; 2019 Feb; 281():47-55. PubMed ID: 30658191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
    Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells.
    Ulleryd MA; Mjörnstedt F; Panagaki D; Yang LJ; Engevall K; Gutiérrez S; Wang Y; Gan LM; Nilsson H; Michaëlsson E; Johansson ME
    Atherosclerosis; 2019 Aug; 287():122-133. PubMed ID: 31260875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis.
    Hannemann C; Schecker JH; Brettschneider A; Grune J; Rösener N; Weller A; Stangl V; Fisher EA; Stangl K; Ludwig A; Hewing B
    Cardiovasc Res; 2022 Jan; 118(1):156-168. PubMed ID: 33576385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.